Logo image of CLDX

CELLDEX THERAPEUTICS INC (CLDX) Stock Analyst Ratings

NASDAQ:CLDX - Nasdaq - US15117B2025 - Common Stock - Currency: USD

18.3  +0.5 (+2.81%)

After market: 18.25 -0.05 (-0.27%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to CLDX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 63.32. This target is 246.04% above the current price.
CLDX was analyzed by 20 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CLDX.
In the previous month the buy percentage consensus was at a similar level.
CLDX was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
CLDX Historical Analyst RatingsCLDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -100 -91 -82 -73 -64 -55 -46 -37 -28 -19 -10 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 18.3036.3664.7763.3294.50 - 98.69% 253.93% 246.04% 416.39%
CLDX Current Analyst RatingCLDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-03-20 Morgan Stanley Initiate Overweight
2025-03-03 Goldman Sachs Maintains Neutral -> Neutral
2025-03-03 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-13 UBS Initiate Buy
2025-01-29 Cantor Fitzgerald Reiterate Overweight -> Overweight
2025-01-02 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-12-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-19 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-07 Citigroup Initiate Buy
2024-09-30 Goldman Sachs Initiate Neutral
2024-09-27 Wolfe Research Downgrade Outperform -> Peer Perform
2024-09-26 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-25 Wolfe Research Reiterate Outperform -> Outperform
2024-09-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-18 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-12 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-08-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-30 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-30 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-18 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-11 Wolfe Research Initiate Outperform
2024-06-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-15 HC Wainwright & Co. Reiterate Buy -> Buy